Balance of transforming growth factor-beta1 and platelet-derived growth factor-BB is associated with kidney allograft...

Area of Science:

• Nephrology
• Transplantation Immunology
• Biomarker Discovery

Background:

• Chronic allograft nephropathy (CAN) is a primary cause of kidney transplant failure, leading to graft loss in 50-80% of long-term survivors.
• The exact pathogenesis of CAN is complex, but TGF-β1 and PDGF-BB expression in CAN suggests their potential involvement in arteriosclerosis and graft failure.

Purpose of the Study:

• To investigate the association between plasma concentrations of specific growth factors and the occurrence of CAN in kidney transplant recipients.
• To explore the potential of TGF-β1 and PDGF-BB as early molecular markers for graft deterioration.

Main Methods:

• Plasma concentrations of human growth factors were measured using enzyme-linked immunosorbent assays (ELISAs).
• Statistical analysis, including the computation of odds ratios, was employed to correlate growth factor expression levels with CAN occurrence.
• The study included 129 kidney transplant patients and 15 healthy controls.

Main Results:

• A statistically significant association was found between CAN and a specific balance of plasma concentrations of TGF-β1 and PDGF-BB.
• Odds ratios confirmed the correlation between these growth factor expression levels and the likelihood of CAN.

Conclusions:

• The findings suggest that the balance between TGF-β1 and PDGF-BB plasma levels may serve as a novel non-invasive indicator for early detection of kidney transplant graft deterioration.
• This could pave the way for improved monitoring and management strategies for kidney transplant recipients.